The clinical management and therapeutic influence over the concentration of glycated hemoglobin (HbA1c), a key biomarker reflecting the average plasma glucose concentration over the preceding two to three months. Effective regulation signifies tight, long-term glycemic control, which is paramount for preventing microvascular and macrovascular complications.
Origin
The concept is rooted in the discovery of hemoglobin glycation and its clinical application as a retrospective measure of blood sugar control, evolving into a cornerstone of diabetes and metabolic syndrome management. Regulation extends beyond diet and exercise to include pharmacologic and hormonal interventions.
Mechanism
HbA1c is formed through a non-enzymatic reaction between hemoglobin and glucose in the bloodstream, a process termed glycation, which is directly proportional to the average glucose concentration. Regulation is achieved by modulating insulin sensitivity, glucose production, and glucose disposal pathways via targeted lifestyle changes, anti-diabetic medications, or hormones like GLP-1 agonists, aiming to reduce the total glucose exposure of red blood cells.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.